Bispectral Index Under Propofol Anesthesia in Children : a Study Between TIVA and TCI
Launched by PR ISABELLE CONSTANT · Dec 21, 2015
Trial Information
Current as of May 16, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • weighting more than 15 kg;
- • American Society of Anesthesiologists physical status I or II
- • scheduled for middle ear surgery
- Exclusion Criteria:
- • cardiovascular, neurological, hepatic or renal impairment, if their body mass index was above 95th percentile or if they received any drug interfering with the central nervous system.
About Pr Isabelle Constant
Dr. Isabelle Constant is a distinguished clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a background in clinical pharmacology and extensive experience in overseeing diverse clinical trials, Dr. Constant emphasizes rigorous scientific methodology and ethical standards. Her leadership is characterized by a collaborative approach, fostering partnerships with research institutions and healthcare professionals to drive innovation in therapeutic development. Dr. Constant is dedicated to ensuring that clinical studies not only meet regulatory requirements but also prioritize patient safety and efficacy, ultimately contributing to the advancement of healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Trial Officials
Isabelle Constant, PhD
Study Director
Hôpital Armand Trousseau
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials